Asimple test for immunogenicity of colloidal infusion solutions- the draining lymph node activation

Area of Science:

• Immunology
• Biochemistry
• Pharmacology

Background:

• Assessing the immunogenicity of infusion solutions is crucial for drug safety.
• Traditional methods for determining immunogenicity can be time-consuming and costly.

Purpose of the Study:

• To establish a rapid and economical assay for evaluating the immunogenicity of infusion solutions.
• To identify a reliable biological marker for immune response to administered substances.

Main Methods:

• Lymphocytes with RNA-synthesizing nucleoli in mouse lymph nodes were used as a marker.
• Mice were injected with various infusion solutions, including bovine serum, human haemoglobin, Physiogel, Dextran, and Duxon.
• The percentage of "active" lymphocytes was measured 3 days post-administration.

Main Results:

• A significant increase in "active" lymphocytes was observed 3 days after administration of bovine serum and human haemoglobin preparations.
• These preparations were confirmed as immunogenic through antibody formation testing.
• No significant increase in "active" lymphocytes was observed in mice treated with Physiogel, Dextran, and Duxon, which did not elicit antibody production.

Conclusions:

• The percentage of lymphocytes synthesizing RNA serves as a reliable indicator of a substance's immunogenicity.
• This lymphocyte activation assay offers a rapid and cost-effective method for screening infusion solutions and other substances for potential immune responses.
• The findings support the use of this assay in preclinical safety assessments of new pharmaceutical preparations.